Hong Kong stock anomaly | AJA -B (02617.HK) surges nearly 14% Recently announced positive clinical results for enfortumab vedotin in a subsidiary of "The Lancet"

According to the Wise News App, China Traditional Chinese Medicine Holdings Co., Ltd. (02617.HK) surged by nearly 14%, as of the time of publication, up by 13.85% to 166.1 Hong Kong dollars, with a turnover of 1.12 billion Hong Kong dollars.